Home Applications 021923 Application 021923
Type NDA
Sponsor BAYER HLTHCARE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NEXAVAR SORAFENIB TOSYLATE TABLET;ORAL EQ 200MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021923-001 NEXAVAR SORAFENIB TOSYLATE EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021923-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL RLD, RS 2005-12-20 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021923-001 NEXAVAR EQ 200MG BASE TABLET / ORAL AB RLD, RS 2005-12-20 cb3db0bc1861…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 6 · 218 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021923-001 8877933 2027-12-24 U-1624 Drug substance, Drug product 2014-12-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021923-001 9737488 2028-09-10 U-2107 Drug product 2017-09-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021923-001 9737488 2028-09-10 U-1480 Drug product 2017-09-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021923-001 9737488 2028-09-10 U-1696 Drug product 2017-09-20 d06236e962d9…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Nexavar SORAFENIB Bayer HealthCare Pharmaceuticals Inc. b50667e4-5ebc-4968-a646-d605058dbef0 2023-08-28 Warnings, Adverse reactions Exact identifier application applno (NDA): 021923 application number: NDA021923 ndc (product): 50419-488
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 12 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-488 Nexavar sorafenib Bayer HealthCare Pharmaceuticals Inc. NDA Current